|
SMMT Summit Therapeutics Inc 1599298 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-215,700,000.00 |
| Balance Sheet |
|
Current Assets
|
$720,578,000.00 |
|
Assets
|
$752,185,000.00 |
|
Current Liabilities
|
$103,566,000.00 |
|
Liabilities
|
$122,202,000.00 |
|
Equity
|
$629,983,000.00 |
|
Shares Out
|
793120362.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-263,415,000.00 |
|
Investing Cash Flow
|
$222,658,000.00 |
| Market Analysis |
Market Cap
|
$9,858,486,099.66 |
|
Price
|
$12.43 |
|
BVPS
|
0.79 |
|
PB
|
15.73 |
|
EPS
|
-0.28 |
|
FCF
|
$-264,569,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:19 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:11 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-23 |
-0.14 |
|
| Apr |
May |
Jun |
|
|
2026-04-30 |
-0.15 |
|
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.12 |
|
| Oct |
Nov |
Dec |
|
|
2025-10-20 |
-0.13 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SMMT documents filed with the SEC.
SMMT Filings
Clear
